Profile data is unavailable for this security.
About the company
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
- Revenue in USD (TTM)27.71m
- Net income in USD-284.69m
- Incorporated2012
- Employees480.00
- LocationUniqure NVPaasheuvelweg 25aAMSTERDAM 1105 BPNetherlandsNLD
- Phone+31 202406000
- Fax+31 202406020
- Websitehttp://www.uniqure.com/